Z94.0 is a billable ICD code used to specify a diagnosis of kidney transplant status. A 'billable code' is detailed enough to be used to specify a medical diagnosis. Documentation insufficient to determine if the condition was present at the time of inpatient admission. Clinically undetermined.
End stage renal disease. N18.6 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM N18.6 became effective on October 1, 2018.
Unspecified transfusion reaction, initial encounter
The 2022 edition of ICD-10-CM T86.10 became effective on October 1, 2021.
Use secondary code (s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code. Type 1 Excludes.
The 2022 edition of ICD-10-CM T86.19 became effective on October 1, 2021.
Use secondary code (s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code. Type 1 Excludes.
The 2022 edition of ICD-10-CM T86.13 became effective on October 1, 2021.
Use secondary code (s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code. Type 1 Excludes.
A common complication of kidney transplant is rejection of the transplanted organ. The body’s immune system, or defense mechanism, recognizes that something foreign is in the body and tries to destroy it
Diabetes mellitus, hypertension, cystic kidney disease, urologic conditions, and external causes such as trauma and toxins, all may cause kidney failure. When kidneys cease to filter wastes and extra fluid from the bloodstream, renal failure is considered to be permanent and consideration must be given to hemodialysis and/or kidney transplantation.
Kidney transplantation is a treatment option for most patients with End Stage Renal Disease (ESRD). The procedure may be deceased-donor (cadaveric) or living-donor transplantation. Living-donor renal transplants may be genetically related (living-related) or non-related (living-unrelated) transplants.
A kidney transplant may not fully restore function to the kidney, and some residual kidney disease could be present. Without the link provided by the physician, coders should report V42.7 with an additional code for the CKD. Physicians may also document in the medical record of the post-kidney transplant recipient ESRD.
Two codes are necessary to completely classify a transplant complication. One code identifies the transplanted organ (996.8x). The fifth digit subclassification is required to identify the specific organ affected, while the second code is needed to identify the complication.
After a patient receives a transplanted organ, several complications may occur. The most serious complication is rejection, which occurs when the recipient’s immune system attacks the transplanted organ. The symptoms the patient may experience will vary depending on the transplanted organ.
It is appropriate to assign code V42.0, Kidney replaced by transplant, with a code from category 585 if no transplant complication is documented. However, if a transplant complication (such as transplant failure or rejection) is documented, assign code 996.81, Complications of transplanted kidney. Query the physician for clarification if the documentation is unclear regarding the presence of a transplant complication (AHA Coding Clinic for ICD-9-CM, 2006, fourth quarter, pages 180 and 200).
Kidney transplant rejection can be classified as cellular rejection or antibody-mediated rejection. Antibody-mediated rejection can be classified as hyperacute, acute, or chronic, depending on how long after the transplant it occurs. If rejection is suspected, a kidney biopsy should be obtained.
Kidney transplant or renal transplant is the organ transplant of a kidney into a patient with end-stage kidney disease (ESRD). Kidney transplant is typically classified as deceased-donor (formerly known as cadaveric) or living-donor transplantation depending on the source of the donor organ. Living-donor kidney transplants are further characterized ...
The transplant surgery takes about three hours . The donor kidney will be placed in the lower abdomen and its blood vessels connected to arteries and veins in the recipient's body. When this is complete, blood will be allowed to flow through the kidney again. The final step is connecting the ureter from the donor kidney to the bladder. In most cases, the kidney will soon start producing urine.
In 2018, an estimated 95,479 kidney transplants were performed worldwide, 36% of which came from living donors. The first successful kidney transplant was performed by Joseph Murray in 1954; Murray was awarded the Nobel Prize in Physiology or Medicine in 1990 for his work in organ transplantation.
The major barrier to organ transplantation between genetically non-identical patients lay in the recipient's immune system, which would treat a transplanted kidney as a 'non-self' and immediately or chronically reject it. Thus, having medication to suppress the immune system was essential.
The relationship the donor has to the recipient has evolved over the years. In the 1950s, the first successful living donor transplants were between identical twins. In the 1960s–1970s, live donors were genetically related to the recipient. However, during the 1980s–1990s, the donor pool was expanded further to emotionally related individuals (spouses, friends). Now the elasticity of the donor relationship has been stretched to include acquaintances and even strangers ('altruistic donors'). In 2009, US transplant recipient Chris Strouth received a kidney from a donor who connected with him on Twitter, which is believed to be the first such transplant arranged entirely through social networking.
However, kidney transplant recipients must remain on immunosuppressants (medications to suppress the immune system) for the rest of their life to prevent their body from rejecting the new kidney. This long-term immunosuppression puts them at higher risk for infections and cancer.